Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK-733

Known as: MK 733, MK733 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1992
Highly Cited
1992
The effect of simvastatin (MK-733), a potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on the… Expand
1990
1990
The preventive effects of simvastatin (MK-733) and pravastatin (CS-514), 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase… Expand
1990
1990
Abstract A new antihypercholesterolemic drug, simvastatin (MK-733), which is a prodrug of a potent3-hydroxy-3-methylglutaryl… Expand
Review
1989
Review
1989
The efficacy of simvastatin, a new inhibitor of cholesterol biosynthesis, was studied in patients with familial… Expand
1989
1989
MK-733 (simvastatin), a potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, was found to inhibit the… Expand
Highly Cited
1989
Highly Cited
1989
MK-733 was found to prevent an increase of serum cholesterol levels in cholesterol-fed rabbits, and lovastatin also markedly… Expand
Highly Cited
1988
Highly Cited
1988
The power of serum lathosterol concentration as an indicator of whole-body cholesterol synthesis was investigated in 47 human… Expand
  • table 2
  • figure 1
  • table 3
  • table 4
Highly Cited
1988
Highly Cited
1988
Simvastatin (MK-733), a new inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, was administered to 38 patients with… Expand
1988
1988
Effects of MK-733 on the absorption and excretion of cholesterol in rabbits were examined using [3H]cholesterol. The animals were… Expand
Highly Cited
1986
Highly Cited
1986
The effects of synvinolin (MK-733), a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, were investigated… Expand